Provided by Tiger Trade Technology Pte. Ltd.

Kodiak Sciences Inc.

91.08
-1.2600-1.36%
Pre-market: 90.45-0.6300-0.69%07:27 EDT
Volume:1.31M
Turnover:120.27M
Market Cap:5.70B
PE:-21.91
High:94.25
Open:91.74
Low:89.91
Close:92.34
52wk High:104.00
52wk Low:10.94
Shares:62.58M
Float Shares:36.99M
Volume Ratio:0.41
T/O Rate:3.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1571
EPS(LYR):-4.3220
ROE:-368.37%
ROA:-60.45%
PB:93.29
PE(LYR):-21.07

Loading ...

Kodiak Sciences Announces First Patients Enrolled in Global Phase 3 Alto Trial of Ksi-501 in Patients with Diabetic Macular Edema

THOMSON REUTERS
·
Aug 11

Kodiak Sciences (KOD) Is Up 9.1% After Advancing KSI-101 Phase 3 PEAK Trial Enrollment – Has The Bull Case Changed?

Simply Wall St.
·
Aug 09

Analysts Are Bullish on These Healthcare Stocks: Climb Bio (CLYM), Kodiak Sciences (KOD)

TIPRANKS
·
Aug 07

Kodiak Sciences - Completes Enrollment in First Phase 3 Peak Cohort; Topline Data Expected December 2026

THOMSON REUTERS
·
Aug 06

Berenberg Bank Remains a Buy on Kodal Minerals (KOD)

TIPRANKS
·
Jul 20

Is Kodiak Sciences’ (KOD) Shift Into Russell Growth Indices Reframing Its Core Investment Story?

Simply Wall St.
·
Jul 04

Kodiak Sciences CFO John A. Borgeson disposes of common shares worth $1.02 million

Reuters
·
Jun 06

Kodiak Sciences shareholders elect Class II directors at annual meeting

Reuters
·
Jun 05

Kodiak Sciences CEO to present at Jefferies Global Healthcare Conference

Reuters
·
May 29

Kodiak Sciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

Kodiak Sciences upgraded to Buy from Neutral at Chardan

TIPRANKS
·
May 12

Stock Track | Kodiak Sciences Soars 5.66% Intraday on Analyst Upgrade and Raised Price Target

Stock Track
·
May 11

Chardan Upgrades Kodiak Sciences to Buy From Neutral, Raises Price Target to $61 From $14

MT Newswires Live
·
May 11

Kodiak Sciences Raised to Buy From Neutral by Chardan Capital

Dow Jones
·
May 11

Analysts Offer Insights on Healthcare Companies: Kodiak Sciences (KOD), IN8bio (INAB) and Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
May 11

LifeSci Capital Remains a Buy on Kodiak Sciences (KOD)

TIPRANKS
·
May 08

Kodiak Sciences Q1 EPS $(0.94) Misses $(0.92) Estimate

Benzinga Earnings
·
May 08

Kodiak Sciences Q1 FY26 net loss widens to $58.2 million; R&D expenses rise to $48.5 million

Reuters
·
May 08

BRIEF-Kodiak Sciences Q1 Net Income USD -58.158 Million

Reuters
·
May 08

Kodiak Sciences Q1 Basic EPS USD -0.94

THOMSON REUTERS
·
May 08